SUN Pharmaceutical Industries Limited — Amphotericin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Amphotericin · $3.8M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Amphotericin with $3.8M in export value and 76 verified shipments. SUN Pharmaceutical Industries Limited holds a 6.2% market share in Amphotericin exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Amphotericin Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Amphotericin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.5M | 52 | 78.2% |
| AUSTRALIA | $550.3K | 23 | 16.9% |
| SOUTH AFRICA | $100.0K | 4 | 3.1% |
| THAILAND | $57.5K | 3 | 1.8% |
| BRAZIL | $12 | 3 | 0.0% |
| HUNGARY | $0 | 1 | 0.0% |
SUN Pharmaceutical Industries Limited exports Amphotericin to 6 countries. The largest destination is UNITED STATES accounting for 78.2% of SUN Pharmaceutical Industries Limited's Amphotericin shipments, followed by AUSTRALIA (16.9%) and SOUTH AFRICA (3.1%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amphotericin from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $900.0K | 18 |
| SUN PHARMACEUTICAL INDUSTRIES,INC | UNITED STATES | $645.3K | 14 |
| SUN PHARMACEUTICAL INDUSTRIES INC | UNITED STATES | $350.0K | 7 |
| SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $250.0K | 7 |
| SUN PHARMACEUTICAL INDUSTRIES,INC.. | UNITED STATES | $250.0K | 5 |
| SUN PHARMA ANZ PTY LTD | AUSTRALIA | $250.0K | 5 |
| SUN PHARMACEUTICAL INDUSTRIES,INC, | UNITED STATES | $200.0K | 4 |
| SUN PHARMACEUTICAL INDUSTRIESINC.. | UNITED STATES | $150.0K | 3 |
| RANBAXY PHARMACEUTICALS PTY(LTD) | SOUTH AFRICA | $50.0K | 1 |
| SUN PHARMACEUTICAL INDUSTRIESINC | UNITED STATES | $50.0K | 1 |
SUN Pharmaceutical Industries Limited supplies Amphotericin to 19 buyers globally. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), followed by SUN PHARMACEUTICAL INDUSTRIES,INC (UNITED STATES) and SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amphotericin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $28.0M worth of Amphotericin through 1,226 shipments from 180 suppliers to 116 countries, serving 390 buyers globally. SUN Pharmaceutical Industries Limited contributes $3.8M to this total, accounting for 6.2% of India's Amphotericin exports. SUN Pharmaceutical Industries Limited ships Amphotericin to 6 countries through 19 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Amphotericin Exports?
SUN Pharmaceutical Industries Limited's average Amphotericin shipment value is $50.0K per consignment, based on 76 shipments totaling $3.8M. The largest destination is UNITED STATES (78.2% of SUN Pharmaceutical Industries Limited's Amphotericin exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Amphotericin Exporters?
SUN Pharmaceutical Industries Limited ranks #2 among 180 Indian Amphotericin exporters with a 6.2% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($15.8M), EMCURE PHARMACEUTICALS LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.8M). SUN Pharmaceutical Industries Limited processed 76 shipments to 6 destination countries.
What Amphotericin Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50 | $600.0K | 14 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL(FOR US) PACK : 01*01 | $315.6K | 7 |
| LIPOSO AMPHO INJ 50MG/VIAL 1S VIAL AUS/ LIPOSOMAL AMPHOTERICIN B AMPHOTERICIN POWDER FOR INJECTION 50 MG/VIAL | $150.0K | 3 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL(FOR US)- (PACK : 01*01) | $150.0K | 3 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL [6852 PACK X 1X1] | $100.0K | 2 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL(FOR US) -1x20ml, PACK : 01*01,Batch : BAF0366A MFD : 24.08.2024 EXP : | $100.0K | 2 |
| LIPOSO AMPHO INJ 50MG/VIAL 1'S VIAL AUS/ Liposomal Amphotericin B (Amphotericin) Powder for Injection 50 mg/vial PACK : | $100.0K | 2 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/ VIAL PACK : 01*01 (BATCH NO AS PER INVOICE) | $100.0K | 2 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL (PACK : 01 X 01) | $100.0K | 2 |
| AMPHOTERICIN B LIPOSOME FOR INJECTION 50MG/VIAL(FOR US)-[2160 PACK X1X1] | $79.7K | 2 |
SUN Pharmaceutical Industries Limited exports 55 distinct Amphotericin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMPHOTERICIN B LIPOSOME FOR INJECTION 50 with 14 shipments worth $600.0K.
Regulatory Requirements: Exporting Amphotericin to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Amphotericin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Amphotericin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BHARAT SERUMS AND VACCINES LIMITED | $15.8M | 315 | 47 | $50.0K |
| 3 | EMCURE PHARMACEUTICALS LIMITED | $4.5M | 89 | 7 | $50.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $3.8M | 76 | 6 | $50.0K |
| 8 | CIPLA LIMITED | $750.0K | 15 | 4 | $50.0K |
| 6 | CARITAS HEALTHCARE PRIVATE LIMITED | $600.0K | 12 | 1 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #2 among 180 Indian Amphotericin exporters. Average shipment value of $50.0K compared to the market average of $155.4K. The closest competitors by value are BHARAT SERUMS AND VACCINES LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Amphotericin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 352 | 28.7% |
| SAHAR AIR | 345 | 28.1% |
| Bombay Air | 119 | 9.7% |
| DELHI AIR | 65 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 5.1% |
| NHAVA SHEVA SEA (INNSA1) | 38 | 3.1% |
| Bombay Air Cargo | 31 | 2.5% |
| BANGALORE ACC (INBLR4) | 20 | 1.6% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Amphotericin Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Amphotericin, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amphotericin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amphotericin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 86 individual customs records matching SUN Pharmaceutical Industries Limited exporting Amphotericin, covering 55 formulations to 6 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 116+ countries, 390+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amphotericin Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Amphotericin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Amphotericin Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amphotericin. For current shipment-level data, contact TransData Nexus.